Henrik Green

Professor

My research aim to improve cancer chemotherapy by predicting pharmacokinetics and side effects. I also work a lot in forensic sciences.

Presentation

Genetics and Toxicology in Cancer Chemotherapy and Forensic Sciences

My research is focused on finding predictive markers and understanding how pharmaceutiacls and drugs yield desired and undesired effects in humans.

Everyone is different and everyone reacts differently to drugs. Our research group studies how genetic variation affects the effect and risk of side effects in cancer treatment. We also work with new psychoactive drugs (internet drugs), their toxicology and pharmacology. Our third track is genetics in a forensic perspective.

Publications

2023

News

Male researcher in lab, blue background light.

Faster narcotics classification of Internet drugs with new method

NPS, new psychoactive substances, are substances developed to affect the brain in a similar way to illegal drugs. Researchers have set up a rapid method for measuring the effect of new NPS and provide scientific basis for narcotics classification.

Estrogen possible risk factor in disturbed heart rhythm

The sex hormone estrogen has a negative impact on heartbeat regulation, according to an experimental study from LiU. Estrogen impact seems to interact with hereditary changes causing a heart disease disturbing the heart’s rhythm.

Research to combat designer drugs

Researchers are involved in the campaign to make designer drugs illegal as quickly as possible. Henrik Gréen investigates how new psychoactive substances act, and why some designer drugs are more lethal than others.

Research

Strategic Research Area in Forensic Sciences

The Strategic Research Area in Forensic Sciences is a joint venture between the National Board of Forensic Medicine in Sweden and Linköping University.

LiU Cancer

LiU Cancer is a research network at Linköping University and the Region Östergötland. The network includes independent researchers and their groups whose research is related to cancer diagnosis, pathogenesis and treatment.

LiU Cancer

Publications

Latest publications

2023

About me

CV

Currently:

Research strategist / Molecular Biologist in Engineering and Genomics. Department of Forensic Genetics and Forensic Toxicology, National Board of Forensic Medicine, Linköping.
Associate Professor at Division of Drug Research, Department of Medical and Health Sciences, Faculty of Medical Sciences, Linköping University.
2011--2012. Post-doc at Science for Life Laboratory, Division of Gene technology, Institution for Biotechnology, KTH - Royal Institute of Technology.
2007 - 2012. Assistant Professor at the Division of Drug Research, Linköping University, Linköping Sweden.

Education

2000 - Master of Science in Engineering Biology. Institute of Technology, Linköping University, Linköping, Sweden.
2007 - PhD in Clinical Pharmacology. Division of Clinical Pharmacology, Department of medicine and Care, Faculty of Health Sciences, Linköping University, Linköping, Sweden.
2012 - Associate Professor in Pharmacogenetics at Linköping University.

Co-workers

Robert Kronstrand

Adjunct Professor

Martin Josefsson

Adjunct Associate Professor, Docent

Peter Konradsson

Professor

Johan Dahlén

Associate Professor, Docent

Elisabeth Åvall Lundqvist

Professor

Organisation

Division of Clinical Chemistry and Pharmacology (KKF)

The Division of Clinical Chemistry and Pharmacology (KKF) is a division at the Department of Biomedical and Clinical Sciences. The division is a merger of the previous divisions of Clinical Chemistry and Drug Research.

Faculty of Medicine and Health Sciences (MEDFAK)

The Faculty of Medicine and Health Sciences conducts research and education within medicine, healthcare and public health.

Henrik Green

Presentation

Publications

2023

News

Faster narcotics classification of Internet drugs with new method